MDGL Operating Cash Flow (Statement)
Madrigal Pharmaceuticals Inc · Operating Cash Flow (Statement)
MDGL Operating Cash Flow (Statement)
Latest reported-$197.72Mperiod ending
MDGL TTM Cash from Operations ($27.22M → -$197.72M)
TTM operating cash flow (statement)
High-resolution chart · PNG
MDGL operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -197,716,000 | |
| -268,097,000 | |
| -189,553,000 | |
| -160,579,000 | |
| -307,413,000 | |
| -395,306,000 | |
| -455,572,000 | |
| -431,019,000 | |
| -448,955,000 | |
| -389,320,000 | |
| -324,230,000 | |
| -302,812,000 | |
| -276,961,000 | |
| -259,011,000 | |
| -224,857,000 | |
| -214,393,000 | |
| -200,880,000 | |
| -190,401,000 | |
| -183,917,000 | |
| -190,813,000 | |
| -193,107,000 | |
| -170,484,000 | |
| -157,561,000 | |
| -114,896,000 | |
| -78,370,000 | |
| -65,652,000 | |
| -41,624,000 | |
| -35,607,000 | |
| -29,521,000 | |
| -23,341,000 | |
| -25,507,000 | |
| -25,187,000 | |
| -24,900,000 | |
| -27,190,000 | |
| -22,317,000 | |
| -21,652,033 | |
| -9,744,620 | |
| -9,164,620 | |
| -17,607,620 | |
| -31,664,587 | |
| -54,223,000 | |
| -64,883,000 | |
| -71,444,000 | |
| -71,322,000 | |
| -74,286,000 | |
| -77,430,000 | |
| -78,925,000 | |
| -78,400,000 | |
| -76,422,000 | |
| -75,467,000 | |
| -77,411,000 | |
| -71,244,000 | |
| -67,919,000 | |
| -61,095,000 | |
| -54,135,000 | |
| -52,098,000 | |
| -50,656,000 | |
| -49,715,000 | |
| -47,300,000 | |
| -45,026,000 | |
| -41,630,000 | |
| -38,449,000 | |
| -38,199,000 | |
| -37,252,000 | |
| -37,077,000 | |
| -51,625,000 | |
| -26,810,000 | |
| -2,993,000 | |
| -14,573,000 | |
| -9,993,000 | |
| -37,939,000 | |
| 13,882,000 | |
| 18,306,000 | |
| 24,680,000 | |
| 27,222,000 | |
| -52,167,000 | |
| -50,128,000 |